Amedisys Inc (AMED) Holdings Increased by California Public Employees Retirement System

California Public Employees Retirement System raised its holdings in shares of Amedisys Inc (NASDAQ:AMED) by 4.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 64,785 shares of the health services provider’s stock after purchasing an additional 2,485 shares during the period. California Public Employees Retirement System’s holdings in Amedisys were worth $3,625,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. boosted its stake in Amedisys by 0.7% during the 2nd quarter. Vanguard Group Inc. now owns 2,386,046 shares of the health services provider’s stock valued at $149,867,000 after purchasing an additional 16,368 shares during the last quarter. American Century Companies Inc. boosted its stake in Amedisys by 41.4% during the 3rd quarter. American Century Companies Inc. now owns 1,671,680 shares of the health services provider’s stock valued at $93,547,000 after purchasing an additional 489,220 shares during the last quarter. Wells Fargo & Company MN boosted its stake in Amedisys by 29.7% during the 3rd quarter. Wells Fargo & Company MN now owns 1,484,041 shares of the health services provider’s stock valued at $83,048,000 after purchasing an additional 339,825 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Amedisys by 5.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,184,424 shares of the health services provider’s stock valued at $66,280,000 after purchasing an additional 59,481 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in Amedisys by 10.8% during the 3rd quarter. Bank of New York Mellon Corp now owns 846,575 shares of the health services provider’s stock valued at $47,375,000 after purchasing an additional 82,247 shares during the last quarter. Institutional investors and hedge funds own 94.44% of the company’s stock.

Several research firms have recently weighed in on AMED. Mizuho raised Amedisys from a “neutral” rating to a “buy” rating and increased their price target for the company from $55.00 to $65.00 in a report on Thursday, November 2nd. Benchmark raised Amedisys from a “hold” rating to a “buy” rating and set a $56.00 price target on the stock in a report on Thursday, November 2nd. Craig Hallum reissued a “buy” rating and set a $68.00 price target (up from $55.00) on shares of Amedisys in a report on Thursday, November 9th. Jefferies Group reissued a “buy” rating and set a $60.00 price target on shares of Amedisys in a report on Thursday, October 12th. Finally, SunTrust Banks reissued a “buy” rating and set a $60.00 price target on shares of Amedisys in a report on Monday, October 9th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $61.00.

Amedisys Inc (AMED) opened at $54.76 on Friday. The firm has a market capitalization of $1,850.57, a price-to-earnings ratio of 26.09, a PEG ratio of 1.17 and a beta of 0.71. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.33 and a current ratio of 1.33. Amedisys Inc has a twelve month low of $43.07 and a twelve month high of $65.91.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Tuesday, November 7th. The health services provider reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.02. The firm had revenue of $380.20 million for the quarter, compared to analysts’ expectations of $384.59 million. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The company’s revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 EPS. sell-side analysts predict that Amedisys Inc will post 2.24 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was first published by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.thestockobserver.com/2018/01/13/amedisys-inc-amed-holdings-increased-by-california-public-employees-retirement-system.html.

Amedisys Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply